tradingkey.logo
tradingkey.logo
Search

USD/CAD tests key 200-DMA support zone – Société Générale

FXStreetDec 5, 2025 9:44 AM
facebooktwitterlinkedin
View all comments0

USD/CAD is pressing into major support at the 200-day average and the base of its multi-month channel near 1.3920/1.3880, Société Générale's FX analysts note.

Break below 1.3880 opens path to 1.3830, 1.3770

"USD/CAD has pulled back towards the lower limit of a multi-month channel and the 200-DMA at 1.3920/1.3880. It will be interesting to see if the pair can maintain above this zone. A brief bounce is possible, however, recent highs near 1.4150 may provide resistance."

"In case the pair fails to defend the moving average, the decline may extend. The next objectives could be located at 1.3830 and September low of 1.3770/1.3725."

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.